Caitlin Green is a Gastroenterology physician affiliated with Medical University of South Carolina. OpenAlex indexes 24 publications with 1,215 citations (h-index 9); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
171 Ashley Ave
Charleston, SC 29425
Telephone
843-792-1414Registry record last updated 13 Aug 2018.
Clinical trials
- A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome
Sponsor: Medical University of South Carolina
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20241 payment
- Janssen Scientific Affairs, LLCProgram year20231 payment
- ABBVIE INC.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
89%Proton pump inhibitor31.1%Omeprazole54%Pantoprazole Sodium20%Esomeprazole Magnesium13%Lansoprazole7%Dexlansoprazole Dr6%Part D<11 patientsH2 blocker15.8%Famotidine100%Part D≥37 patients+ 9 more classes in this area
Nervous system
6.9%Other antidepressants5.1%Mirtazapine100%Part D<11 patientsTricyclic Antidepressant1.8%Amitriptyline Hcl100%Part D<11 patientsRespiratory
4.1%Corticosteroid2.1%Budesonide Dr100%Part D<11 patientsPhenothiazine2.1%Promethazine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Letter: Is Enteric Neuropathy Absent in Hypermobility Spectrum Disorders/Hypermobile Ehlers‐Danlos Syndrome?
Alimentary Pharmacology & Therapeutics
2025 - The Impact of the COVID-19 Pandemic on the Care of Pregnant Women with a Focus on Those who Use Substances: Lessons for the Future
Disaster Medicine and Public Health Preparedness
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Tanya Turan, MD
Medical University of South Carolina
Michael Zile, MD
Medical University of South Carolina
Don Rockey, MD
Medical University of South Carolina
William Creasman, MD
Medical University of South Carolina
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”